ResearchMoz

Chicken Pox Clinical Trials Review, Q4, 2010

Publisher Name » GlobalData
Published Date » 2010-11-30
No. Of Pages » 36

GlobalData's clinical trial report, “Chicken Pox Global Global Clinical Trials Review, Q4, 2010""” provides data on the Chicken Pox clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Chicken Pox. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Chicken Pox. 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

1. Table of Contents
1. Table of Contents 2
1.1. List of Tables 4
1.2. List of Figures 5

2. Introduction 6
2.1. Chicken Pox 6
2.2. Report Guidance 6

3. Clinical Trials by Region 7
3.1. Clinical Trials by Country 8
3.1.1. Top Countries Contributing to Clinical Trials in Asia-Pacific 10
3.1.2. Top Five Countries Contributing to Clinical Trials in Europe 11
3.1.3. Top Countries Contributing to Clinical Trials in North America 12
3.1.4. Top Countries Contributing to Clinical Trials in Central and South America 13
3.2. Clinical Trials by BRIC Nations 14

4. Clinical Trials by Phase 15
4.1. In Progress Trials by Phase 16

5. Clinical Trials by Trial Status 17

6. Unaccomplished Trials of Chicken Pox 18

7. Subjects Recruited Over a Period of Time 19

8. Prominent Sponsors 21
8.1. Top Companies Participating in Chicken pox Clinical Trials 23

9. Prominant Drug Comparison 25

10. Clinical Trial Profiles 26
10.1. Clinical Trial Overview of Top Companies 26
10.1.1. GlaxoSmithKline plc 26
10.1.2. Merck & Co., Inc. 28
10.1.3. Sanofi Pasteur MSD 29
10.1.4. Novartis AG 30
10.2. Clinical Trial Overview of Top Universities / Institutes / Hospitals 30
10.2.1. The National Institute of Allergy and Infectious Diseases 30
10.2.2. National Center for Complementary and Alternative Medicine 31
10.2.3. The Hospital for Sick Children 31
10.2.4. University of Rochester 32

11. Appendix 33
11.1. Abbreviations 33
11.2. Definitions 33
11.3. Research Methodology 34
11.4. Secondary Research 35
11.5. About GlobalData 35
11.6. Contact Us 35
11.7. Disclaimer 36
11.8. Source 36

List of Tables


Table 1: Chicken Pox Therapeutics Market, Global, Clinical Trials by Zone, 2010* 7
Table 2: Chicken Pox Therapeutics Clinical Trials and in Progress Trials Market, Global, by Top Countries, 2010* 9
Table 3: Chicken Pox Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2010* 10
Table 4: Chicken Pox Therapeutics Clinical Trials, Europe, Top Five Countries, 2010* 11
Table 5: Chicken Pox Therapeutics Clinical Trials, North America, Top Five Countries, 2010* 12
Table 6: Chicken Pox Therapeutics Clinical Trials, Central and South America, Top Countries, 2010* 13
Table 7: Chicken Pox Therapeutics Clinical Trials, BRIC Countries, 2010* 14
Table 8: Chicken Pox Therapeutics Market, Global, Clinical Trials by Phase, 2010* 15
Table 9: Chicken Pox Therapeutics Market, Global, Clinical Trials In Progress by Phase 2010* 16
Table 10: Chicken Pox Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 17
Table 11: Chicken Pox Therapeutics Market, Global, Terminated Clinical Trials, 2010* 18
Table 12: Chicken Pox Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 20
Table 13: Checken Pox Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 22
Table 14: Chicken Pox Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 24
Table 15: Chicken Pox Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010* 25
Table 16: Chicken Pox Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2010* 26
Table 17: Chicken Pox Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2010* 28
Table 18: Chicken Pox Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi Pasteur MSD, 2010* 29
Table 19: Chicken Pox Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2010* 30
Table 20: Chicken Pox Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2010* 30
Table 21: Chicken Pox Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2010* 31
Table 22: Chicken Pox Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2010* 31
Table 23: Chicken Pox Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2010* 32

List of Figures


Figure 1: Chicken Pox Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 7
Figure 2: Chicken Pox Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 8
Figure 3: Chicken Pox Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2010* 9
Figure 4: Chicken Pox Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2010* 10
Figure 5: Chicken Pox Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 11
Figure 6: Chicken Pox Therapeutics Clinical Trials, North America, Top Five Countries (%), 2010* 12
Figure 7: Chicken Pox Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2010* 13
Figure 8: Chicken Pox Therapeutics Clinical Trials, BRIC Countries (%), 2010* 14
Figure 9: Chicken Pox Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 15
Figure 10: Chicken Pox Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2010* 16
Figure 11: Chicken Pox Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 17
Figure 12: Chicken Pox Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 19
Figure 13: Checken Pox Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 21
Figure 14: Chicken Pox Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 23
Figure 15: Chicken Pox Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010* 25
Figure 16: GlobalData Methodology 34

Upcoming Reports:

Image Sensors Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012-2018
By - Transparency Market Research
Image sensors are used for improving quality control and product yield in different production environments. These sensors are integrated in different applications to reduce costs by understanding key technology and market trends.  Moreover, the improved condition after the economic crisis is contributing to the growth of this sector. Common applications of image sensors include biometrics, digital camera, camcorders, videoconferencing, optical mice, virtual keyboards, etc.  Problems such as image quality and automation can restrict the market growth rate. Growing...
Building-Integrated Photovoltaics (BIPV) Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Building integrated photovoltaics (BIPV) market makes up an important part of current world Photovoltaics market. The global market for BIPV is expected to reach the capacity of 11,392 megawatts by the year 2015 at the compounded annual growth rate of 56%. Among the various segments of this market, BIPV roofing is the largest segments accounting for 3,197 megawatts by year 2015 with the CAGR of 51%. Increase in the demand for energy and rapidly depleting energy sources are creating the need for alternative energy sources. Building integrated photovoltaics will enable...
Power Management ICs Market 2011-2018 - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Power management integrated circuits (PMICs) are used to manage a server’s power requirements. PMICs are included in battery operated devices such as media players and mobile phones. Demand for PMICs is increasing due to the rising demand for portable gadgets with multiple functionalities. The global PMIC market also includes LED lighting, electric vehicles, energy harvesting and renewable energy markets. The global market for PMICs has shown remarkable progress in recent years and is also showing attractive market potential for the future. The global PMICs market has...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...